MeSH term
Frequency | Condition_Probility | Animals | 47 | 0.0 |
Caseins/*genetics | 2 | 28.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Cells, Cultured | 9 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Female | 35 | 0.0 |
Humans | 79 | 0.0 |
Mice | 17 | 0.0 |
*Milk Proteins | 14 | 2.0 |
Phosphorylation | 13 | 0.0 |
Prolactin/*pharmacology | 7 | 8.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 59 | 0.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
Tyrosine/metabolism | 6 | 0.0 |
src Homology Domains | 3 | 0.0 |
Base Sequence | 16 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Receptors, Prolactin/*genetics | 11 | 64.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Protein Isoforms/genetics/metabolism | 2 | 1.0 |
Adult | 16 | 0.0 |
Comparative Study | 8 | 0.0 |
Prolactin/*blood | 3 | 0.0 |
Radioimmunoassay | 2 | 0.0 |
Receptors, Prolactin/*metabolism | 13 | 52.0 |
Male | 17 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 8 | 0.0 |
Receptors, Prolactin/chemistry/*metabolism | 2 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
*Signal Transduction | 7 | 0.0 |
3T3 Cells | 2 | 0.0 |
Binding Sites | 7 | 0.0 |
Enzyme Activation | 5 | 0.0 |
Ligands | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 5 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transfection | 12 | 0.0 |
rac1 GTP-Binding Protein/metabolism | 2 | 2.0 |
Breast Neoplasms | 5 | 1.0 |
Cell Line | 12 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Prolactin/pharmacology | 7 | 18.0 |
Amino Acid Sequence | 5 | 0.0 |
Cell Division/drug effects | 9 | 0.0 |
Gene Expression | 4 | 0.0 |
Kinetics | 8 | 0.0 |
RNA/analysis | 2 | 0.0 |
Signal Transduction | 10 | 0.0 |
Tumor Cells, Cultured | 20 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors | 2 | 2.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Mutation | 3 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Rats | 19 | 0.0 |
Receptors, Prolactin/genetics | 3 | 60.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
Middle Aged | 13 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Prognosis | 4 | 0.0 |
Receptors, Prolactin/metabolism | 4 | 25.0 |
Cell Nucleus/chemistry | 2 | 1.0 |
Cytoplasm/chemistry | 2 | 1.0 |
*Gene Expression | 4 | 0.0 |
Growth Hormone/pharmacology | 4 | 11.0 |
In Situ Hybridization | 2 | 0.0 |
Receptors, Somatotropin/*genetics | 2 | 3.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Prolactin/genetics/*metabolism/pharmacology | 2 | 100.0 |
*Proto-Oncogene Proteins | 14 | 0.0 |
Trans-Activators/metabolism | 4 | 0.0 |
Cell Differentiation | 3 | 0.0 |
MAP Kinase Signaling System | 2 | 0.0 |
Prolactin/*physiology | 4 | 10.0 |
Protein-Tyrosine Kinase/physiology | 2 | 1.0 |
Receptors, Prolactin/physiology | 2 | 22.0 |
Trans-Activators/physiology | 2 | 1.0 |
Cell Division | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Chi-Square Distribution | 2 | 0.0 |
Proportional Hazards Models | 2 | 0.0 |
Reference Values | 4 | 0.0 |
Breast Neoplasms/*metabolism | 5 | 1.0 |
Growth Hormone/*physiology | 2 | 7.0 |
Prolactin/*metabolism | 4 | 6.0 |
CHO Cells | 5 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Hamsters | 7 | 0.0 |
Placental Lactogen/*pharmacology | 2 | 66.0 |
Receptors, Prolactin/*chemistry/genetics | 2 | 100.0 |
Receptors, Somatotropin/*chemistry/genetics | 2 | 66.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Sheep | 5 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Receptors, Prolactin/*genetics/metabolism | 3 | 60.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Testis/*metabolism | 2 | 2.0 |
Blotting, Western | 3 | 0.0 |
Breast Neoplasms/*pathology | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Down-Regulation | 2 | 0.0 |
Receptors, Prolactin/drug effects | 2 | 50.0 |
Cell Survival/drug effects | 2 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Receptors, Estrogen/*metabolism | 2 | 0.0 |
Adolescent | 4 | 0.0 |
Child | 2 | 0.0 |
Cattle | 5 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Exons | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Pregnancy | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Receptors, Prolactin/*physiology | 3 | 50.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Binding, Competitive | 4 | 0.0 |
Biological Assay | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Prolactin/metabolism/pharmacology | 2 | 33.0 |
Protein Binding | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Caseins/genetics | 2 | 18.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Receptors, Progesterone/analysis | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
Breast Neoplasms/*genetics/metabolism | 2 | 1.0 |
Receptors, Estrogen/analysis | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Receptors, Prolactin/genetics/*metabolism | 4 | 66.0 |
Structure-Activity Relationship | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Transcription, Genetic/*drug effects | 3 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
RNA, Messenger/analysis/metabolism | 2 | 1.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Prolactin/metabolism | 2 | 3.0 |
Signal Transduction/*physiology | 3 | 0.0 |
Lymphoma | 2 | 5.0 |
Molecular Weight | 2 | 0.0 |
Receptors, Prolactin/*genetics/*metabolism | 2 | 66.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Breast Neoplasms/drug therapy/*pathology | 2 | 28.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
Clone Cells | 2 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Epithelial Cells/cytology | 2 | 2.0 |
Age Factors | 3 | 0.0 |
Receptors, Prolactin | 2 | 10.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Protein Isoforms | 2 | 0.0 |
